TY - JOUR
T1 - Optical Control of Adenosine-Mediated Pain Modulation
AU - Hüll, Katharina
AU - Fernández-Dueñas, Víctor
AU - Schönberger, Matthias
AU - López-Cano, Marc
AU - Trauner, Dirk
AU - Ciruela, Francisco
N1 - Funding Information:
K.H. thanks the Studienstiftung des deutschen Volkes for a Ph.D. scholarship. D.T. was supported by the European Research Council (Advanced Grant 268795) and thanks go to the Centre for Integrated Protein Science Munich (CIPSM). The Shared Instrumentation Facility at the New York University Department of Chemistry was supported by a NIH Research Facilities Improvement Award (C06 RR-16572-01) and a NIH S10 grant (OD016343). This work was supported by FEDER-EU/Ministerio de Ciencia, Innovación y Universidades-Agencia Estatal de Investigación (PID2020-118511RB-I00) and Generalitat de Catalunya (2017SGR1604) to FC.
Funding Information:
We thank Centres de Recerca de Catalunya (CERCA) Programme/Generalitat de Catalunya for IDIBELL institutional support. K determinations were generously provided by the National Institute of Mental Health’s Psychoactive Drug Screening Program, Contract # HHSN-271-2018-00023-C (NIMH PDSP). The NIMH PDSP is Directed by Bryan L. Roth MD, PhD at the University of North Carolina at Chapel Hill and Project Officer Jamie Driscoll at NIMH, Bethesda MD, USA. i
Publisher Copyright:
© 2021 American Chemical Society.
PY - 2021/9/15
Y1 - 2021/9/15
N2 - Adenosine receptors (ARs) play many important roles in physiology and have been recognized as potential targets for pain relief. Here, we introduce three photoswitchable adenosine derivatives that function as light-dependent agonists for ARs and confer optical control to these G protein-coupled receptors. One of our compounds, AzoAdenosine-3, was evaluated in the classical formalin model of pain. The molecule, active in the dark, was not metabolized by adenosine deaminase and effectively reduced pain perception in a light-dependent manner. These antinociceptive effects suggested a major role for A1R and A3R in peripheral-mediated pain sensitization, whereas an average adenosine-mediated antinociceptive effect will be facilitated by A2AR and A2BR. Our results demonstrate that a photoswitchable adenosine derivative can be used to map the contribution of ARs mediating analgesia in vivo.
AB - Adenosine receptors (ARs) play many important roles in physiology and have been recognized as potential targets for pain relief. Here, we introduce three photoswitchable adenosine derivatives that function as light-dependent agonists for ARs and confer optical control to these G protein-coupled receptors. One of our compounds, AzoAdenosine-3, was evaluated in the classical formalin model of pain. The molecule, active in the dark, was not metabolized by adenosine deaminase and effectively reduced pain perception in a light-dependent manner. These antinociceptive effects suggested a major role for A1R and A3R in peripheral-mediated pain sensitization, whereas an average adenosine-mediated antinociceptive effect will be facilitated by A2AR and A2BR. Our results demonstrate that a photoswitchable adenosine derivative can be used to map the contribution of ARs mediating analgesia in vivo.
UR - http://www.scopus.com/inward/record.url?scp=85114644928&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85114644928&partnerID=8YFLogxK
U2 - 10.1021/acs.bioconjchem.1c00387
DO - 10.1021/acs.bioconjchem.1c00387
M3 - Article
C2 - 34448572
AN - SCOPUS:85114644928
SN - 1043-1802
VL - 32
SP - 1979
EP - 1983
JO - Bioconjugate Chemistry
JF - Bioconjugate Chemistry
IS - 9
ER -